Elevance Health Inc. (0HG8.L)
USD 408.81
(-1.12%)
USD 408.81
(-1.12%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -46.33 Billion USD | -307.1% |
| 2022 | -11.38 Billion USD | 70.43% |
| 2021 | -38.48 Billion USD | -12.09% |
| 2020 | -34.33 Billion USD | -18.17% |
| 2019 | -29.05 Billion USD | -13.7% |
| 2018 | -25.55 Billion USD | 29.54% |
| 2017 | -36.26 Billion USD | -5.68% |
| 2016 | -34.31 Billion USD | -57.96% |
| 2015 | -21.72 Billion USD | 6.1% |
| 2014 | -23.13 Billion USD | -0.01% |
| 2013 | -23.13 Billion USD | -9.28% |
| 2012 | -21.16 Billion USD | -3.01% |
| 2011 | -20.54 Billion USD | -0.57% |
| 2010 | -20.43 Billion USD | -7.01% |
| 2009 | -19.09 Billion USD | -245.33% |
| 2008 | -5.52 Billion USD | -366.33% |
| 2007 | -1.18 Billion USD | 66.42% |
| 2006 | -3.53 Billion USD | 21.82% |
| 2005 | -4.51 Billion USD | 70.77% |
| 2004 | -15.44 Billion USD | -120.08% |
| 2003 | -7.01 Billion USD | -16.08% |
| 2002 | -6.04 Billion USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | -11.19 Billion USD | 100.0% |
| 2024 Q1 | -54.04 Billion USD | -0.08% |
| 2024 Q2 | -17.67 Billion USD | 67.3% |
| 2023 FY | -46.33 Billion USD | -307.1% |
| 2023 Q3 | -35.69 Billion USD | -380.34% |
| 2023 Q4 | -54 Billion USD | -51.3% |
| 2023 Q1 | -12.92 Billion USD | -13.56% |
| 2023 Q2 | -7.43 Billion USD | 42.5% |
| 2022 Q2 | -99.01 Billion USD | -144.96% |
| 2022 Q4 | -11.38 Billion USD | 72.49% |
| 2022 FY | -11.38 Billion USD | 70.43% |
| 2022 Q1 | -40.42 Billion USD | 12.58% |
| 2022 Q3 | -41.37 Billion USD | 58.22% |
| 2021 Q2 | -31.68 Billion USD | -3.31% |
| 2021 FY | -38.48 Billion USD | -12.09% |
| 2021 Q3 | -37.31 Billion USD | -17.78% |
| 2021 Q4 | -46.24 Billion USD | -23.92% |
| 2021 Q1 | -30.66 Billion USD | 10.83% |
| 2020 Q1 | -25.66 Billion USD | 15.13% |
| 2020 FY | -34.33 Billion USD | -18.17% |
| 2020 Q4 | -34.39 Billion USD | -22.61% |
| 2020 Q3 | -28.05 Billion USD | -2.1% |
| 2020 Q2 | -27.47 Billion USD | -7.04% |
| 2019 FY | -29.05 Billion USD | -13.7% |
| 2019 Q3 | -24.84 Billion USD | -2.72% |
| 2019 Q4 | -30.24 Billion USD | -21.73% |
| 2019 Q1 | -22.86 Billion USD | 12.14% |
| 2019 Q2 | -24.18 Billion USD | -5.77% |
| 2018 Q3 | -21.79 Billion USD | -1.23% |
| 2018 FY | -25.55 Billion USD | 29.54% |
| 2018 Q2 | -21.52 Billion USD | -25.78% |
| 2018 Q4 | -26.02 Billion USD | -19.42% |
| 2018 Q1 | -17.11 Billion USD | 34.64% |
| 2017 Q2 | -18.96 Billion USD | -5.55% |
| 2017 FY | -36.26 Billion USD | -5.68% |
| 2017 Q4 | -26.18 Billion USD | -39.94% |
| 2017 Q3 | -18.71 Billion USD | 1.33% |
| 2017 Q1 | -17.96 Billion USD | 30.2% |
| 2016 Q3 | -18.23 Billion USD | 1.93% |
| 2016 FY | -34.31 Billion USD | -57.96% |
| 2016 Q2 | -18.59 Billion USD | -1.18% |
| 2016 Q1 | -18.37 Billion USD | 24.32% |
| 2016 Q4 | -25.74 Billion USD | -41.21% |
| 2015 Q1 | -18.83 Billion USD | 23.88% |
| 2015 Q2 | -18.27 Billion USD | 2.95% |
| 2015 Q3 | -17.91 Billion USD | 1.96% |
| 2015 Q4 | -24.27 Billion USD | -35.53% |
| 2015 FY | -21.72 Billion USD | 6.1% |
| 2014 Q4 | -24.73 Billion USD | -33.69% |
| 2014 Q3 | -18.5 Billion USD | -0.39% |
| 2014 Q1 | -18.02 Billion USD | 19.23% |
| 2014 Q2 | -18.43 Billion USD | -2.23% |
| 2014 FY | -23.13 Billion USD | -0.01% |
| 2013 Q4 | -22.32 Billion USD | -26.08% |
| 2013 FY | -23.13 Billion USD | -9.28% |
| 2013 Q2 | -17.79 Billion USD | 0.22% |
| 2013 Q1 | -17.83 Billion USD | 18.08% |
| 2013 Q3 | -17.7 Billion USD | 0.52% |
| 2012 Q3 | -213 Million USD | 98.85% |
| 2012 Q1 | - USD | 100.0% |
| 2012 Q4 | -21.77 Billion USD | -10121.78% |
| 2012 FY | -21.16 Billion USD | -3.01% |
| 2012 Q2 | -18.49 Billion USD | 0.0% |
| 2011 FY | -20.54 Billion USD | -0.57% |
| 2011 Q4 | -21.56 Billion USD | -21.61% |
| 2011 Q1 | - USD | 100.0% |
| 2011 Q2 | -18.1 Billion USD | 0.0% |
| 2011 Q3 | -17.73 Billion USD | 2.06% |
| 2010 Q1 | - USD | 100.0% |
| 2010 FY | -20.43 Billion USD | -7.01% |
| 2010 Q2 | -100.1 Million USD | 0.0% |
| 2010 Q4 | -21.27 Billion USD | 0.0% |
| 2010 Q3 | - USD | 100.0% |
| 2009 Q2 | -59.1 Million USD | 0.0% |
| 2009 Q3 | 505 Million USD | 954.48% |
| 2009 Q4 | -4.16 Billion USD | -923.86% |
| 2009 FY | -19.09 Billion USD | -245.33% |
| 2009 Q1 | - USD | 100.0% |
| 2008 Q4 | -4.57 Billion USD | -7411.02% |
| 2008 Q1 | -4.56 Billion USD | 58.26% |
| 2008 Q2 | 883.7 Million USD | 119.35% |
| 2008 FY | -5.52 Billion USD | -366.33% |
| 2008 Q3 | 62.6 Million USD | -92.92% |
| 2007 Q3 | -4.81 Billion USD | 1.42% |
| 2007 Q4 | -10.94 Billion USD | -127.03% |
| 2007 FY | -1.18 Billion USD | 66.42% |
| 2007 Q2 | -4.88 Billion USD | -8.99% |
| 2007 Q1 | -4.48 Billion USD | 52.52% |
| 2006 Q3 | -3.17 Billion USD | -18.17% |
| 2006 FY | -3.53 Billion USD | 21.82% |
| 2006 Q4 | -9.44 Billion USD | -197.64% |
| 2006 Q2 | -2.68 Billion USD | 18.27% |
| 2006 Q1 | -3.28 Billion USD | 85.91% |
| 2005 Q1 | - USD | 100.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | -15.58 Billion USD | 0.0% |
| 2005 FY | -4.51 Billion USD | 70.77% |
| 2005 Q4 | -23.32 Billion USD | -49.68% |
| 2004 Q4 | -16.69 Billion USD | -129.2% |
| 2004 Q3 | -7.28 Billion USD | -11.56% |
| 2004 Q2 | -6.52 Billion USD | 9.52% |
| 2004 FY | -15.44 Billion USD | -120.08% |
| 2004 Q1 | -7.21 Billion USD | 12.9% |
| 2003 Q2 | -6.7 Billion USD | -4.36% |
| 2003 Q3 | -6.55 Billion USD | 2.35% |
| 2003 Q4 | -8.28 Billion USD | -26.44% |
| 2003 FY | -7.01 Billion USD | -16.08% |
| 2003 Q1 | -6.42 Billion USD | 9.09% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | -6.04 Billion USD | 0.0% |
| 2002 Q4 | -7.07 Billion USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | Infinity% |
| Accuray Incorporated | 138.32 Million USD | 33595.272% |
| Align Technology, Inc. | 296.9 Million USD | 15705.149% |
| AxoGen, Inc. | 23.02 Million USD | 201368.462% |
| Boston Scientific Corporation | 2.48 Billion USD | 1965.217% |
| CVS Health Corporation | 18.02 Billion USD | 357.043% |
| Cardinal Health, Inc. | 14.95 Billion USD | 409.768% |
| Centene Corporation | - USD | Infinity% |
| DaVita Inc. | 143.1 Million USD | 32476.227% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 2392.528% |
| Hologic, Inc. | 679.8 Million USD | 6915.534% |
| Humana Inc. | - USD | Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 12283.59% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 9862.326% |
| Masimo Corporation | 545 Million USD | 8601.284% |
| McKesson Corporation | 21.13 Billion USD | 319.178% |
| Patterson Companies, Inc. | 782.89 Million USD | 6018.012% |
| Quest Diagnostics Incorporated | 190 Million USD | 24485.263% |
| ResMed Inc. | 822.25 Million USD | 5734.783% |
| Henry Schein, Inc. | 1.81 Billion USD | 2652.727% |
| Teladoc Health, Inc. | 29.51 Million USD | 157088.446% |
| Universal Health Services, Inc. | 216.98 Million USD | 21452.333% |
| Veeva Systems Inc. | - USD | Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 1740.652% |
| Becton, Dickinson and Company | 3.27 Billion USD | 1515.582% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 3895.838% |
| Danaher Corporation | 2.59 Billion USD | 1886.122% |
| Stryker Corporation | 4.84 Billion USD | 1056.68% |
| Medtronic plc | 5.21 Billion USD | 988.097% |